Here’s What Analysts Think About Biogen Inc. (BIIB)

Biogen Inc. (NASDAQ:BIIB) is 1 of the champion performing pharma stocks successful 2025. Biogen Inc. (NASDAQ:BIIB) received respective standing updates connected January 8. Truist lifted the terms people connected the banal to $190 from $142 but maintained a Hold rating, telling investors successful a probe enactment that portion it updated its model, the cardinal views stay the aforesaid arsenic 2025.

The aforesaid day, Biogen Inc. (NASDAQ:BIIB) besides received standing updates from Goldman Sachs and Mizuho. Goldman Sachs raised the terms people connected the banal to $225 from $197 portion keeping a Buy standing connected the shares. It expects momentum to proceed successful 2026 aft beardown assemblage show successful 2025, supported by improving fundamentals, marketplace dynamics, and easing argumentation risks. These factors, on with their secondary effects specified arsenic M&A, persist, according to the firm.

Mizuho, connected the different hand, lifted the terms people connected Biogen Inc. (NASDAQ:BIIB) to $207 from $177 and maintained an Outperformed rating, stating that it updated the company’s exemplary since 2026 is “looking a spot better” for Biogen Inc. (NASDAQ:BIIB).

Biogen Inc. (NASDAQ:BIIB) is simply a planetary biopharmaceutical institution that discovers, develops, and delivers precocious therapies for superior diseases crossed the globe. Its medicine portfolio treats aggregate sclerosis (MS), spinal muscular atrophy (SMA), Alzheimer’s disease, and amyotrophic lateral sclerosis (ALS). The institution has an elaborate marketed merchandise portfolio for MS, including TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA. It besides markets SPINRAZA to dainty SMA, SKYCLARYS for the attraction of Friedreich’s Ataxia, and different drugs.

While we admit the imaginable of BIIB arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you’re looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double successful 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This nonfiction is primitively published at Insider Monkey.